Acorda Therapeutics Inc. (ACOR)
NASDAQ: ACOR
· Real-Time Price · USD
0.66
-0.21 (-24.14%)
At close: Apr 03, 2024, 3:59 PM
Acorda Therapeutics Revenue
Acorda Therapeutics reported an annual revenue of $117.63M, reflecting a -0.79% growth. For the quarter ending March 31, 2024, Acorda Therapeutics generated $20.29M in revenue.
Revenue (ttm)
117.63M
Revenue Growth
-0.79%
Price / Sales Ratio
0.03
Revenue / Employee
1.15M
Employees
102
Market Cap
821.03K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 117.63M | -0.79% |
| Dec 31, 2022 | 118.57M | -8.14% |
| Dec 31, 2021 | 129.07M | -15.62% |
| Dec 31, 2020 | 152.97M | -20.50% |
| Dec 31, 2019 | 192.41M | -59.19% |
| Dec 31, 2018 | 471.43M | -19.86% |
| Dec 31, 2017 | 588.29M | +13.22% |
| Dec 31, 2016 | 519.6M | +5.47% |
| Dec 31, 2015 | 492.66M | +22.71% |
| Dec 31, 2014 | 401.48M | +19.34% |
| Dec 31, 2013 | 336.43M | +10.01% |
| Dec 31, 2012 | 305.81M | +4.65% |
| Dec 31, 2011 | 292.24M | +53.00% |
| Dec 30, 2010 | 191M | +249.36% |
| Dec 31, 2009 | 54.67M | +14.31% |
| Dec 31, 2008 | 47.83M | +21.12% |
| Dec 31, 2007 | 39.49M | +44.37% |
| Dec 31, 2006 | 27.35M | +431.55% |
| Dec 31, 2005 | 5.15M | +973.11% |
| Dec 31, 2004 | 479.5K | -43.98% |
| Dec 31, 2003 | 856K | n/a |